Trial intelligence / Profile preview

Long-term follow-up after REC + in situ-forming gel for lumbar canal stenosis

jRCT1010230005Active, not recruiting

Sponsor
Hokkaido University
Start
May 2023
Countries
1
01

Overview

Randomised, double-blind trial in lumbar spinal stenosis (LSS) and Herniated Lumbar Disk (3 arms), sponsored by Hokkaido University. Primary endpoints: Safety (48–96 weeks adverse events), Pain intensity (VAS for low back and leg pain) and 1 more. Started May 2023; status: active, not recruiting.

02

Conditions

lumbar spinal stenosis (LSS)Herniated Lumbar Disk

Beyond the preview

Go deeper on jRCT1010230005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1010230005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call